Literature DB >> 24743788

Discordance between train-of-four response and clinical symptoms in a patient with amyotrophic lateral sclerosis.

Young Jin Chang1, Wol Seon Jung, Woon Rak Son, Young Yi Jo.   

Abstract

A 47-year-old woman with amyotrophic lateral sclerosis was scheduled for total thyroidectomy with cervical node dissection. During anesthetic management by total intravenous anesthesia using remifentanil, propofol, and rocuronium, train-of-four (TOF) monitoring findings were not consistent with clinical signs. Sugammadex successfully reversed shallow respiration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24743788     DOI: 10.18926/AMO/52409

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  5 in total

Review 1.  Amyotrophic lateral sclerosis and anesthesia: a case series and review of the literature.

Authors:  Alan M Hoeper; David W Barbara; James C Watson; Juraj Sprung; Toby N Weingarten
Journal:  J Anesth       Date:  2019-01-17       Impact factor: 2.078

2.  Use of sugammadex in a patient with progressive muscular atrophy and in a patient with amyotrophic lateral sclerosis: Case report.

Authors:  Jae Hwa Yoo; Soon Im Kim; Sun Young Park; Mi Roung Jun; Yong Eun Kim; Hyoung June Kim
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

3.  Incomplete recovery from rocuronium-induced muscle relaxation in patients with amyotrophic lateral sclerosis using sugammadex: A case report.

Authors:  Hea Rim Chun; Jinhun Chung; Nan Seol Kim; A Joo Kim; Suro Kim; Kyu Sik Kang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

4.  Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports.

Authors:  Usha Gurunathan; Shakeel Meeran Kunju; Lisa May Lin Stanton
Journal:  BMC Anesthesiol       Date:  2019-11-19       Impact factor: 2.217

Review 5.  Advantages and pitfalls of clinical application of sugammadex.

Authors:  Hyung Young Lee; Ki Tae Jung
Journal:  Anesth Pain Med (Seoul)       Date:  2020-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.